DORIPENEM - modern carbapenem antibiotic for the effective, safe and economical treatment of nosocomial infections
Нозокомиальные инфекции (НКИ) развиваются у пациентов в ходе оказания медицинской помощи с частотой 2,5-14,8% и представляют собой грозную проблему, приводя к высоким показателям смертности и значительной стоимости оказываемых медицинских услуг. Возбудители НКИ хорошо изучены, но борьба с ними затру...
Saved in:
| Main Author: | Editorial Article |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC “Publisher OKI”
2020-04-01
|
| Series: | Фармакокинетика и Фармакодинамика |
| Online Access: | https://www.pharmacokinetica.ru/jour/article/view/163 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CLINICAL AND PHARMACOECONOMIC ANALYSIS OF CARBAPENEMS (MEROPENEM, IMIPENEM AND DORIPENEM) IN NOSOCOMIAL PNEUMONIA TREATMENT
by: I. I. Shteynberg, et al.
Published: (2015-03-01) -
Inhaled Antibiotics in the Treatment of Nosocomial Pneumonia
by: A. N. Kuzovlev, et al.
Published: (2013-12-01) -
Nosocomial transmission, adaption and clinical outcomes of carbapenem-resistant hypervirulent Klebsiella pneumoniae
by: Yanjun Liu, et al.
Published: (2025-07-01) -
Current Trends in Antibiotic Resistance of Gram-Negative Pathogens of Nosocomial Infections in the Rostov Region
by: O. Yu. Kutsevalova, et al.
Published: (2020-05-01) -
In Vitro Antibacterial Interaction of Doripenem and Amikacin against Multidrug-Resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae Isolates
by: Tonny Loho, et al.
Published: (2018-01-01)